NGM Biopharmaceuticals Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
109
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
10
NGM Biopharmaceuticals General Information
Description
Operator of a biopharmaceutical company intended to translate complex, powerful biology with rigor and urgency into life-changing medicines. The company is engaged in developing novel therapeutics based on a scientific understanding of key biological pathways for the treatment of cardio-metabolic, liver, oncologic, and ophthalmic diseases, providing clients with medicines to treat persistent diseases and improve the well-being of their patients.
Contact Information
Website
www.ngmbio.comCorporate Office
- 333 Oyster Point Boulevard
- South San Francisco, CA 94080
- United States
Corporate Office
- 333 Oyster Point Boulevard
- South San Francisco, CA 94080
- United States
NGM Biopharmaceuticals Timeline
NGM Biopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
NGM Biopharmaceuticals Comparisons
Industry
Financing
Details
NGM Biopharmaceuticals Competitors (74)
One of NGM Biopharmaceuticals’s 74 competitors is Madrigal Pharmaceuticals, a Formerly VC-backed company based in West Conshohocken, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Madrigal Pharmaceuticals | Formerly VC-backed | West Conshohocken, PA | ||||
| Iovance Biotherapeutics | Corporation | San Carlos, CA | ||||
| Sangamo Therapeutics | Formerly VC-backed | Richmond, CA | ||||
| Argos Therapeutics | Venture Capital-Backed | Durham, NC | ||||
| BPS Bioscience | Corporation | San Diego, CA |
NGM Biopharmaceuticals Patents
NGM Biopharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026222361-A1 | Ceacam5 and aplp2 binding agents and uses thereof | Pending | 18-Apr-2025 | ||
| AU-2024315708-A1 | Methods of treating nausea and vomiting disorders using anti-gfral antibodies | Pending | 31-Jul-2023 | ||
| EP-4754134-A1 | Methods of treating nausea and vomiting disorders using anti-gfral antibodies | Pending | 31-Jul-2023 | ||
| US-20250074991-A1 | Methods of treating nausea and vomiting disorders using anti-gfral antibodies | Pending | 31-Jul-2023 | ||
| WO-2025029768-A1 | Methods of treating nausea and vomiting disorders using anti-gfral antibodies | Inactive | 31-Jul-2023 | C07K16/2863 |
NGM Biopharmaceuticals Signals
NGM Biopharmaceuticals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
NGM Biopharmaceuticals FAQs
-
When was NGM Biopharmaceuticals founded?
NGM Biopharmaceuticals was founded in 2008.
-
Where is NGM Biopharmaceuticals headquartered?
NGM Biopharmaceuticals is headquartered in South San Francisco, CA.
-
What is the size of NGM Biopharmaceuticals?
NGM Biopharmaceuticals has 109 total employees.
-
What industry is NGM Biopharmaceuticals in?
NGM Biopharmaceuticals’s primary industry is Drug Discovery.
-
Is NGM Biopharmaceuticals a private or public company?
NGM Biopharmaceuticals is a Private company.
-
What is NGM Biopharmaceuticals’s current revenue?
The current revenue for NGM Biopharmaceuticals is .
-
How much funding has NGM Biopharmaceuticals raised over time?
NGM Biopharmaceuticals has raised $122M.
-
Who are NGM Biopharmaceuticals’s investors?
The Column Group has invested in NGM Biopharmaceuticals.
-
Who are NGM Biopharmaceuticals’s competitors?
Madrigal Pharmaceuticals, Iovance Biotherapeutics, Sangamo Therapeutics, Argos Therapeutics, and BPS Bioscience are some of the 74 competitors of NGM Biopharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process